Article Information
History
- September 24, 2020.
Article Versions
- You are currently viewing Version 1 of this article (September 24, 2020 - 14:40).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Ashlee D. Brunaugh1,
- Hyojong Seo1,
- Zachary Warnken1,
- Li Ding1,
- Sang Heui Seo2 and
- Hugh D.C. Smyth1,*
- 1Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, University of Texas at Austin, 2409 University Ave, Austin TX, 78712
- 2Laboratory of Influenza Research, College of Veterinary Medicine, Chungnam National University, 99 Dae-Hak Ro, Yoseong Gu, Dajeon, Korea, 34134
- ↵*Corresponding author; email: hugh.smyth{at}austin.utexas.edu
Posted September 24, 2020.
Broad-Spectrum, Patient-Adaptable Inhaled Niclosamide-Lysozyme Particles are Efficacious Against Coronaviruses in Lethal Murine Infection Models
